GENB (Generate Biomedicines) PB Ratio: (As of Jun. 30, 2026)


GENB Generate Biomedicines Inc GENB
6 GF Score
Price $16.92
! 2 Warning Signs
View Full Analysis

What is Generate Biomedicines PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-30), Generate Biomedicines's share price is $16.92. Generate Biomedicines's Book Value per Share for the quarter that ended in Dec. 2025 was $-4.83. Hence, Generate Biomedicines's PB Ratio of today is .

The historical rank and industry rank for Generate Biomedicines's PB Ratio or its related term are showing as below:

GENB's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.835
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Generate Biomedicines  (NAS:GENB) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Generate Biomedicines PB Ratio Related Terms


Generate Biomedicines PB Ratio Historical Data

* Premium members only.

The historical data trend for Generate Biomedicines's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Generate Biomedicines PB Ratio Chart

Generate Biomedicines Annual Data
Trend Dec24 Dec25
PB Ratio
0.00 0.00

Generate Biomedicines Semi-Annual Data
Dec24 Dec25
PB Ratio 0.00 0.00

GENB vs PVLA, SLBT, NKTR: PB Ratio Comparison

For the Biotechnology subindustry, Generate Biomedicines's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Generate Biomedicines PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Generate Biomedicines's PB Ratio distribution charts can be found below:

* The bar in red indicates where Generate Biomedicines's PB Ratio falls into.


GENB
6GF Score
Generate Biomedicines Inc GENB
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Generate Biomedicines PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Generate Biomedicines's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=16.92/-4.833
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Generate Biomedicines Business Description

Address 101 South Street, Suite 900, Somerville, MA, USA, 02143
Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.
6GF Score

Get the complete analysis for GENB

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.92
Price